The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2019 | Research priorities and trial platforms for lung cancer

Name: Research priorities and trial platforms for lung cancer
Uploaded: 2019-01-25T00:00:00Z
Duration: 2 min 31 s
Description: Matthew Hatton, MSc, MBChB, MRCP, FRCP, FRCR, of the University of Sheffield, Sheffield, UK, discusses the NCRI Lung Cancer Clinical Studies Group research priorities and trial platforms at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.

Matthew Hatton • 25 Jan 2019

BTOG 2019

Lung Cancer Non-Small Cell Lung Cancer

Matthew Hatton, MSc, MBChB, MRCP, FRCP, FRCR, of the University of Sheffield, Sheffield, UK, discusses the NCRI Lung Cancer Clinical Studies Group research priorities and trial platforms at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.